Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder.
J Pharmacol Exp Ther
; 363(3): 377-393, 2017 12.
Article
in En
| MEDLINE
| ID: mdl-28954811
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organophosphates
/
Piperidines
/
Pyrrolidinones
/
Prodrugs
/
Receptors, N-Methyl-D-Aspartate
/
Depressive Disorder, Major
/
Antidepressive Agents
Limits:
Animals
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2017
Document type:
Article
Country of publication:
Estados Unidos